Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
AURA · NASDAQ · Biological Products, (No Diagnostic Substances)
$6.87−0.11 (−1.58%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Aura Biosciences (AURA) · oqro.io/stocks/AURA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
ADAR1 Capital Management, LLC now owns 5.2% of AURA as a passive investorSourceInsider trade · Traded Nov 16, 2026 · Filed Nov 16, 2026
Officer sold ~$119K of AURA shares in the open marketSourcePlanned sale · Planned for Nov 16, 2026 · Notice filed Nov 16, 2026
Officer filed to sell about $119K of AURA stockSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 13, 2026
Montanova Capital, LLC cut its AURA stake below 5% (2.9%)SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed a new position in AURA for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Montanova Capital, LLC disclosed an increased position in AURA for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Frazier Life Sciences Management, L.P. disclosed an increased position in AURA for Q2 2026SourceInsider trade · Traded Aug 18, 2025 · Filed Aug 18, 2025
Officer sold ~$52K of AURA shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Frazier Life Sciences Management, L.P. disclosed a new position in AURA for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Montanova Capital, LLC disclosed an increased position in AURA for Q2 2025SourceInsider trade · Traded May 16, 2025 · Filed May 20, 2025
Officer purchased ~$245K of AURA shares in the open marketSourceInsider trade · Traded May 16, 2025 · Filed May 20, 2025
Director purchased ~$98K of AURA shares in the open marketSourceInsider trade · Traded May 16, 2025 · Filed May 20, 2025
Officer sold ~$7.8K of AURA shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Montanova Capital, LLC disclosed a new position in AURA for Q1 2025SourceInsider trade · Traded Apr 16, 2025 · Filed Apr 17, 2025
Officer sold ~$39K of AURA shares in the open marketSourceInsider trade · Traded Apr 16, 2025 · Filed Apr 17, 2025
Officer sold ~$4.9K of AURA shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 19, 2025
Director sold ~$157K of AURA shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 19, 2025
Officer sold ~$20K of AURA shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 19, 2025
Officer sold ~$17K of AURA shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 19, 2025
Officer sold ~$11K of AURA shares in the open marketSourceInsider trade · Traded Jan 21, 2025 · Filed Jan 22, 2025
Director sold ~$122K of AURA shares in the open marketSourceInsider trade · Traded Jan 21, 2025 · Filed Jan 22, 2025
Officer sold ~$7.7K of AURA shares in the open marketSourceInsider trade · Traded Nov 18, 2024 · Filed Nov 19, 2024
Officer sold ~$111K of AURA shares in the open marketSourceInsider trade · Traded Oct 29, 2024 · Filed Oct 30, 2024
Director sold ~$99K of AURA shares in the open marketSourceInsider trade · Traded Oct 29, 2024 · Filed Oct 30, 2024
Officer sold ~$5.9K of AURA shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 21, 2024
CFO sold ~$302K of AURA shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 19, 2024
Director sold ~$301K of AURA shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Eventide Asset Management, LLC no longer reported AURA for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Eventide Asset Management, LLC disclosed a reduced position in AURA for Q4 2024SourceInsider trade · Traded Oct 16, 2024 · Filed Oct 17, 2024
Officer sold ~$73K of AURA shares in the open marketSource